HCPCS Level II code S3650 identifies a saliva-based hormone test used during menopause to assess hormone levels. As an outpatient diagnostic laboratory service, this code captures noninvasive specimen collection and laboratory analysis intended to evaluate menopausal hormonal status. Nationally, accurate coding for such diagnostic tests matters for clinical documentation, claims processing, and appropriate utilization tracking as interest in less-invasive hormone testing grows.

Key payers covered in this summary include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on clinical utility, typical sites of service, and how this code is categorized within HCPCS Level II. The publication provides benchmarks and policy-relevant information where available, highlights payer coverage considerations, and outlines common billing contexts for saliva hormone testing during menopause.

The content is intended for clinicians, billing professionals, and policy analysts seeking a concise reference on HCPCS Level II code S3650, including what the code represents, its clinical context, and areas to review for payer-specific coverage and claims adjudication. Data not available in the input is noted where applicable.